Epidemiology of hepatocellular carcinoma in sub-Saharan Africa

Published incidences of hepatocellular carcinoma in the Black population of sub-Saharan Africa underestimate the true incidence of the tumor because of the many instances in which hepatocellular carcinoma is either not definitively diagnosed or is not recorded in a cancer registry. Despite this, it...

Full description

Bibliographic Details
Main Author: Michael C. Kew
Format: Article
Language:English
Published: Elsevier 2013-03-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119313547
_version_ 1818608165508349952
author Michael C. Kew
author_facet Michael C. Kew
author_sort Michael C. Kew
collection DOAJ
description Published incidences of hepatocellular carcinoma in the Black population of sub-Saharan Africa underestimate the true incidence of the tumor because of the many instances in which hepatocellular carcinoma is either not definitively diagnosed or is not recorded in a cancer registry. Despite this, it is manifestly evident that the tumor occurs commonly and is a major cause of cancer deaths in Black African peoples living in the sub-continent, particularly in those living in rural areas. 46,000 new cases of hepatocellular carcinoma have been recorded to be diagnosed in sub-Saharan Africa each year, and age-standardized incidences of the tumor as high as 41.2/100,000 persons/year have been documented. The highest incidence of hepatocellular carcinoma has been recorded in Mozambique. The tumor occurs at a young age in rural dwelling and, to a lesser extent, urban dwelling Black Africans. It is also more common in men than women, particularly in the younger patients. Cirrhosis co-exists with hepatocellular carcinoma in about 60% of patients and is equally common in the two sexes. The tumor is not only common in the Black African population, it also carries an especially grave prognosis, with about 93% of the patients dying within 12 months of the onset of symptoms. Caucasians living in the sub-continent have a low incidence of hepatocellular carcinoma and it occurs at an older age.
first_indexed 2024-12-16T14:38:19Z
format Article
id doaj.art-5c740b4165f044e5a94b40494bbd6dff
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-12-16T14:38:19Z
publishDate 2013-03-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-5c740b4165f044e5a94b40494bbd6dff2022-12-21T22:28:02ZengElsevierAnnals of Hepatology1665-26812013-03-01122173182Epidemiology of hepatocellular carcinoma in sub-Saharan AfricaMichael C. Kew0Correspondence and reprint request:; Department of Medicine, Groote Schuur Hospital, and University of Cape Town, Cape Town, and Department of Medicine, University of the Witatersrand, Johannesburg, South AfricaPublished incidences of hepatocellular carcinoma in the Black population of sub-Saharan Africa underestimate the true incidence of the tumor because of the many instances in which hepatocellular carcinoma is either not definitively diagnosed or is not recorded in a cancer registry. Despite this, it is manifestly evident that the tumor occurs commonly and is a major cause of cancer deaths in Black African peoples living in the sub-continent, particularly in those living in rural areas. 46,000 new cases of hepatocellular carcinoma have been recorded to be diagnosed in sub-Saharan Africa each year, and age-standardized incidences of the tumor as high as 41.2/100,000 persons/year have been documented. The highest incidence of hepatocellular carcinoma has been recorded in Mozambique. The tumor occurs at a young age in rural dwelling and, to a lesser extent, urban dwelling Black Africans. It is also more common in men than women, particularly in the younger patients. Cirrhosis co-exists with hepatocellular carcinoma in about 60% of patients and is equally common in the two sexes. The tumor is not only common in the Black African population, it also carries an especially grave prognosis, with about 93% of the patients dying within 12 months of the onset of symptoms. Caucasians living in the sub-continent have a low incidence of hepatocellular carcinoma and it occurs at an older age.http://www.sciencedirect.com/science/article/pii/S1665268119313547EpidemiologyHepatocellular carcinomaSub-Saharan Africa
spellingShingle Michael C. Kew
Epidemiology of hepatocellular carcinoma in sub-Saharan Africa
Annals of Hepatology
Epidemiology
Hepatocellular carcinoma
Sub-Saharan Africa
title Epidemiology of hepatocellular carcinoma in sub-Saharan Africa
title_full Epidemiology of hepatocellular carcinoma in sub-Saharan Africa
title_fullStr Epidemiology of hepatocellular carcinoma in sub-Saharan Africa
title_full_unstemmed Epidemiology of hepatocellular carcinoma in sub-Saharan Africa
title_short Epidemiology of hepatocellular carcinoma in sub-Saharan Africa
title_sort epidemiology of hepatocellular carcinoma in sub saharan africa
topic Epidemiology
Hepatocellular carcinoma
Sub-Saharan Africa
url http://www.sciencedirect.com/science/article/pii/S1665268119313547
work_keys_str_mv AT michaelckew epidemiologyofhepatocellularcarcinomainsubsaharanafrica